Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy
We describe the second case of teriparatide therapy for treatment of ONJ that was unresponsive
to conventional therapies. Bisphosphonates are one of the most prescribed drugs in …
to conventional therapies. Bisphosphonates are one of the most prescribed drugs in …
Understanding and managing corticosteroid-induced osteoporosis
…, D Herman, A Papaioannou, AN Lau… - Open Access …, 2021 - Taylor & Francis
Glucocorticoids are effective immunosuppressants used in a wide variety of diseases. Their
use results in secondary osteoporosis in about 30–50% of chronic glucocorticoid users. …
use results in secondary osteoporosis in about 30–50% of chronic glucocorticoid users. …
Occurrence of serious infection in patients with rheumatoid arthritis treated with biologics and denosumab observed in a clinical setting
AN Lau, M Wong-Pack, R Rodjanapiches… - The Journal of …, 2018 - jrheum.org
Objective. Previous studies combining biologic disease-modifying antirheumatic drugs (bDMARD)
to treat rheumatoid arthritis (RA) have shown an increased risk of infection. However, …
to treat rheumatoid arthritis (RA) have shown an increased risk of infection. However, …
The relationship between long-term proton pump inhibitor therapy and skeletal frailty
AN Lau, M Tomizza, M Wong-Pack, A Papaioannou… - Endocrine, 2015 - Springer
Proton pump inhibitors (PPIs) are a commonly prescribed class of medications. Their use
has been associated with an increased rate of fractures, most notably hip fractures. However, …
has been associated with an increased rate of fractures, most notably hip fractures. However, …
Romosozumab in the treatment of osteoporosis
Osteoporosis is a disease characterized by weakening of the bone architecture, which
leads to an increased risk of fracture. There has been interest in the development of …
leads to an increased risk of fracture. There has been interest in the development of …
[HTML][HTML] The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer
HO Al-Shamsi, AN Lau, K Malik, A Alamri… - Journal of …, 2012 - hindawi.com
Introduction. ADT is used in the management of locally advanced and metastatic disease.
The detrimental effect of ADT on bone density is well documented. This study assesses care …
The detrimental effect of ADT on bone density is well documented. This study assesses care …
[HTML][HTML] The tissue-selective estrogen complex: a review of current evidence
The tissue-selective estrogen complex (TSEC) has recently entered the market for the treatment
of postmenopausal osteoporosis, and is particularly targeted to women with significant …
of postmenopausal osteoporosis, and is particularly targeted to women with significant …
Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
Glucocorticoids are commonly used in various fields within medicine. One of their most
common and clinically significant side effects is glucocorticoid-induced osteoporosis (GIOP). …
common and clinically significant side effects is glucocorticoid-induced osteoporosis (GIOP). …
[HTML][HTML] What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture …
AN Lau, G Ioannidis, Y Potts, LM Giangregorio… - BMC geriatrics, 2010 - Springer
Background Compared to the general elderly population, those institutionalized in LTC facilities
have the highest prevalence of osteoporosis and subsequently have higher incidences …
have the highest prevalence of osteoporosis and subsequently have higher incidences …
[HTML][HTML] Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
Background Individuals with osteoporosis and recent vertebral fractures suffer from pain
and impaired health-related quality of life (HRQL). To determine whether patients with …
and impaired health-related quality of life (HRQL). To determine whether patients with …